These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37940727)

  • 21. Advances in device-based treatment of heart failure with preserved ejection fraction: evidence from clinical trials.
    Wu Y; Song M; Wu M; Lin L
    ESC Heart Fail; 2024 Feb; 11(1):13-27. PubMed ID: 37986663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.
    Burlacu A; Simion P; Nistor I; Covic A; Tinica G
    Heart Fail Rev; 2019 Sep; 24(5):793-803. PubMed ID: 30949860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy.
    Wang S; Wu S; Xu L; Xiao F; Whinnett ZI; Vijayaraman P; Su L; Huang W
    J Am Heart Assoc; 2019 Dec; 8(24):e014253. PubMed ID: 31830874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Slotwiner DJ; Raitt MH; Del-Carpio Munoz F; Mulpuru SK; Nasser N; Peterson PN
    Circulation; 2019 Aug; 140(8):e483-e503. PubMed ID: 30586773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical utility of direct His-bundle pacing in patients with heart failure and permanent atrial fibrillation.
    Ciesielski A; Boczar K; Siekiera M; Gajek J; Sławuta A
    Acta Cardiol; 2022 Apr; 77(2):114-121. PubMed ID: 34006173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction.
    Ben-Arzi A; Hazanov E; Ghanim D; Rozen G; Marai I; Grosman-Rimon L; Kachel E; Amir O; Carasso S
    BMC Med Imaging; 2021 May; 21(1):76. PubMed ID: 33957873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and safety of both His bundle pacing and left bundle branch area pacing in atrial fibrillation patients: intermediate term follow-up.
    Ye Y; Zhang K; Yang Y; Jiang D; Pan Y; Sheng X; Wang B; Yu C; Zhang Z; Zhang J; Wang L; Jiang J; Sun Y; Liu Q; Cheng Y; Gao B; Wang M; He H; Jiang C; Fu G
    J Interv Card Electrophysiol; 2023 Mar; 66(2):271-280. PubMed ID: 33723691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplified P-wave duration predicts new-onset atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Müller-Edenborn B; Minners J; Kocher S; Chen J; Zeh W; Lehrmann H; Allgeier J; Neumann FJ; Arentz T; Jadidi A
    Clin Res Cardiol; 2020 Aug; 109(8):978-987. PubMed ID: 31863175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    Reddy YNV; Obokata M; Verbrugge FH; Lin G; Borlaug BA
    J Am Coll Cardiol; 2020 Sep; 76(9):1051-1064. PubMed ID: 32854840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Subclinical Heart Failure With Preserved Ejection Fraction in Patients With Symptomatic Atrial Fibrillation.
    Ariyaratnam JP; Elliott AD; Mishima RS; Kadhim K; McNamee O; Kuklik P; Emami M; Malik V; Fitzgerald JL; Gallagher C; Lau DH; Sanders P
    JACC Heart Fail; 2023 Nov; 11(11):1626-1638. PubMed ID: 37676212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
    Reddy YNV; Borlaug BA; Gersh BJ
    Circulation; 2022 Jul; 146(4):339-357. PubMed ID: 35877831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Device Therapy for Heart Failure with Preserved Ejection Fraction.
    Salah HM; Levin AP; Fudim M
    Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
    Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
    Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effects of cardiac resynchronization therapy and right ventricular pacing on the right ventricle in patients with heart failure and atrial fibrillation.
    Majos-Karwacka E; Kraska A; Kowalik I; Smolis-Bak E; Lipiec P; Kasprzak J; Szwed H; Dabrowski R
    Scand Cardiovasc J; 2021 Feb; 55(1):15-21. PubMed ID: 32954833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrioventricular node ablation and His bundle pacing.
    Vijayaraman P; Subzposh FA; Naperkowski A
    Europace; 2017 Dec; 19(suppl_4):iv10-iv16. PubMed ID: 29220422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.